MONDAY, Feb. 7, 2022 (HealthDay News) -- For adults who completed a primary COVID-19 vaccine regimen at least 12 weeks earlier, homologous and heterologous booster vaccines are immunogenic, according to a study published online Jan. 26 in the New England…
